Lion's Mane: Benefits, Dosage, Contraindications
Other name(s)
Lion's Mane
Scientific name(s)
Hericium Erinaceus
Family or group:
Mushrooms
Active ingredients:
Polysaccharides
Indications
Rating methodology
EFSA approval.
Alzheimer's Disease ✪✪✪✪✪
Preliminary clinical research on patients over 50 years old with mild Alzheimer's disease suggests that daily intake of 1 g of Lion's Mane mushroom mycelium (standardized to contain 5 mg of erinacine A per gram) for 49 weeks may improve performance in daily activities compared to a placebo. Moreover, it also improves scores on the Mini-Mental State Examination compared to baseline values. However, the validity of these results is limited by the absence of a control group.
Posologie
Cognitive Decline ✪✪✪✪✪
A clinical trial in middle-aged to elderly adults shows that consuming 3.2 g per day for 12 weeks does not produce significant cognitive function improvements compared to a placebo. Similarly, additional research in young adults indicates that 10 g daily for 4 weeks does not enhance cognitive markers during exercise-induced fatigue compared to a placebo. However, a study in Japanese patients aged 50 to 80 years with mild cognitive impairment shows improvement in cognitive functions after taking 1 g of Lion's Mane powder three times daily for 16 weeks, although cognitive functions regress four weeks after stopping the treatment. In conclusion, Lion's Mane benefits older adults more than healthy young subjects.
Posologie
Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial
Improvement of cognitive functions by oral intake of Hericium erinaceus
Depression ✪✪✪✪✪
Lion's Mane (Hericium erinaceus) has been studied for its potential effects on depression, with mixed results. A clinical study conducted in 2010 on 30 postmenopausal women revealed a decrease in depressive and anxiety symptoms after four weeks of consuming H. erinaceus powder incorporated into cookies. However, this study showed similar improvements in the placebo group, suggesting significant biases potentially related to the study format or placebo effect. More convincing research from 2019 administered 1200 mg of H. erinaceus powder daily (comprising 80% mycelium and 20% fruiting body) to participants for 8 weeks. This study demonstrated a significant improvement in depression and anxiety symptoms, with effects persisting after an 8-week cessation period.
Posologie
Gastritis ✪✪✪✪✪
The extract of Lion's Mane mushroom has shown significant gastroprotective potential by reducing the severity of gastric ulcers in animal models. This efficacy is attributed to the anti-inflammatory and antioxidant properties of mushroom polysaccharides, which favorably regulate inflammatory cytokines and strengthen the gastric mucosal barrier, thereby contributing to better mucosal integrity and reduced gastric acidity. These results encourage further clinical studies to confirm these effects in humans.
Posologie
Properties
Neurological
Lion's Mane shows promising neuroprotective and neurotrophic properties, mainly due to its active compounds such as erinacines and hericenones. These components participate in various key brain mechanisms, positively influencing neuronal and cognitive health. The erinacines, particularly erinacine A present in Lion's Mane, have demonstrated their ability to inhibit the production of beta amyloid protein, involved in the development of Alzheimer's disease. This action reduces amyloid-induced cytotoxicity, thus offering protective effects against the neurodegeneration observed in this disease. Research has also shown that Lion's Mane can improve recognition memory, although it has no notable effect on working spatial memory. Lion's Mane stimulates the synthesis of the nerve growth factor (NGF) in astrocytic cells and the hippocampus in rats, thereby promoting neurite growth. It was believed that the hericenones C, D, and E were responsible for these effects, but researchers discovered that the mushroom acts synergistically in its entirety directly on the gene expression of NGF. These effects, combined with anti-inflammatory properties and the reduction of oxidative stress, make Lion’s Mane a potential candidate for the prevention and treatment of neurodegenerative diseases and neuronal injuries.
Usages associés
High molecular weight of polysaccharides from Hericium erinaceus against amyloid beta-induced neurotoxicity
Protective effects of Hericium erinaceus mycelium and its isolated erinacine A against ischemia-injury-induced neuronal cell death via the inhibition of iNOS/p38 MAPK and nitrotyrosine
Anticancer
Lion's Mane exhibits notable anticancer effects, mainly observed in in vitro studies and animal models. These studies have shown that the extract of this mushroom is cytotoxic against several types of cancer, including liver, colon, and stomach cancers. It acts by stimulating the immune system, inhibiting angiogenesis (formation of new blood vessels that feed tumors), and inducing apoptosis (programmed death of cancer cells). The effectiveness of Lion's Mane against cancer is also attributed to its ability to downregulate the activation of nuclear factor kappa B (NF-kB) and matrix metalloproteinase-9 (MMP-9), molecules involved in angiogenesis and tumor progression. Furthermore, this extract can reduce metastasis by suppressing the expression of enzymes that degrade the extracellular matrix, contributing to the dissemination of cancer cells. Research also suggests that Lion's Mane could enhance the effectiveness of standard chemotherapy treatments or mitigate their undesirable effects. For instance, the cerebroside E component of Lion's Mane could reduce the nephrotoxicity caused by cisplatin while increasing the efficacy of doxorubicin-induced apoptosis in hepatocellular carcinoma cells.
A new cerebroside from the fruiting bodies of Hericium erinaceus and its applicability to cancer treatment
Composition and mechanism of antitumor effects of Hericium erinaceus mushroom extracts in tumor-bearing mice
Hericium erinaceus polysaccharide-protein HEG-5 inhibits SGC-7901 cell growth via cell cycle arrest and apoptosis
Hericium erinaceus Inhibits TNF-α-Induced Angiogenesis and ROS Generation through Suppression of MMP-9/NF-κB Signaling and Activation of Nrf2-Mediated Antioxidant Genes in Human EA.hy926 Endothelial Cells
Gastroprotector
Lion's Mane possesses significant gastroprotective properties, supported by preliminary clinical and animal research. It has interesting potential in the treatment of chronic atrophic gastritis, where an improvement in symptoms and a reduction in inflammation in patients have been observed. In vitro studies have shown that polysaccharides extracted from Lion’s Mane mycelium can interrupt the proliferation of precancerous gastric epithelial cells by inducing cell cycle arrest. This suggests potential in preventing progression into more severe states such as gastric cancer. Moreover, Lion's Mane demonstrates notable antibacterial activity against Helicobacter pylori, a pathogen associated with several gastrointestinal diseases, including gastric ulcers. This activity is attributed to specific components of the mushroom that inhibit the growth of H. pylori. Additionally, animal studies indicate that the aqueous extract of Lion's Mane, administered before ethanol exposure, can reduce the area of ethanol-induced gastric ulcers in rats by protecting the gastric mucosa and inhibiting the infiltration of leucocytes in gastric walls. These studies also suggest that Lion's Mane could regulate gut microbiota, offering a promising therapeutic approach for various gastrointestinal disorders.
Usages associés
Anti-Helicobacter pylori activity of bioactive components isolated from Hericium erinaceus
Modulating effects of Hericium erinaceus polysaccharides on the immune response by regulating gut microbiota in cyclophosphamide-treated mice
Influence of Short-Term Consumption of Hericium erinaceus on Serum Biochemical Markers and the Changes of the Gut Microbiota: A Pilot Study
Cardiovascular
Lion's Mane mushroom extract, when administered with a high-fat diet, moderates the increase of serum and hepatic triglyceride levels in rats. In fact, Lion's Mane contains components that specifically activate PPAR alpha, a type of nuclear receptor in cells. These PPAR alpha receptors play an important role in regulating lipid and carbohydrate metabolism in the body. Furthermore, studies show that polysaccharides from Lion’s Mane can significantly reduce total cholesterol and LDL while increasing HDL through modest inhibition of HMG-CoA reductase and a possible reduction of cholesterol absorption.
Safety dosage
Adult: 1 g - 3 g (standardized extract)
Clinical studies on the Lion's Mane mushroom have used doses ranging from 1000 to 3000 mg, split into three or four daily intakes. Some products using mycelium of this mushroom enriched in erinacine A have been standardized to contain 5 mg/g of erinacine A.
Precautions
Autoimmune diseases: avoid
Lion's Mane appears to stimulate immune function.